510(k) K884591

EBV-VCA ANTIBODY (IGG) by Hillcrest Biologicals — Product Code GNP

K884591 is an FDA 510(k) premarket notification submitted by Hillcrest Biologicals for the device "EBV-VCA ANTIBODY (IGG)". The FDA issued a decision of Substantially Equivalent on January 24, 1989. The device falls under product code GNP (Antiserum, Cf, Epstein-Barr Virus), a Class I device regulated under 21 CFR 866.3235. Hillcrest Biologicals has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 24, 1989
Date Received
November 3, 1988
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antiserum, Cf, Epstein-Barr Virus
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type